참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Ethanolamine | HCID 700 | — |
| 반응물 | (+)-L-Leucine methyl ester | HCID 65105 | — |
| 반응물 | L-Leucinol | HCID 111307 | — |
| 반응물 | 2-Methyl-4-nitrophenyl isothiocyanate | HCID 145621 | — |
| 생성물 | HCID 178428753 | HCID 178428753 | — |
반응 단계
(1S)-1-(Hydroxymethyl)-3-methylbutylamine was made from (L)-leucine methyl ester as described in Method B1b. The 2-hydroxyethylamine was converted to (1S)-1-(chloromethyl)-3-methylbutanammonium chloride as described in Method B7a. 2-Methyl-4-nitrophenyl isothiocyanate was reacted with (1S)-1-(chloromethyl)-3-methylbutanammonium chloride according to Method C1a to give (4S)-2-(2-methyl-4-nitrophenylimino)-4-isobutyl-1,3-thiazolidine. The thiazolidine was reacted with 2-chloro-3,3-dimethyl-2-butanone according to Method D2a to give (4S)-2-(2-methyl-4-nitrophenylimino)-4-isobutyl-3-(2-oxo-3,3-dimethyl-1-butyl)-1,3-thiazolidine. The ketone was reduced according to Method D5a to afford (4S)-2-(2-methyl-4-nitrophenylimino)-4-isobutyl-3-(3,3-dimethyl-2-hydroxy-1-butyl)-1,3-thiazolidine.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US06353006B1 |
|---|
| 출처 데이터셋 | uspto-grants-2002_03 |
|---|
| ORD ID | ord-d59834b6418d4928992c1b46e38f1d35 |
|---|
| 출처 메모 | uspto-grants-2002_03 |
|---|